M Tewar, MD

All articles by M Tewar, MD

Fremanezumab Beneficial in Patients With Chronic Migraine and Moderate to Severe Depression

M Tewar, MD

May 13, 2019

Investigators sought to determine the long-term safety and efficacy of fremanezumab in patients with chronic migraine and comorbid moderate to severe depression.

Depressive Disorder

Assessment and Treatment of Depression: A Clinical Look at the Current Controversies

M Tewar, MD

October 30, 2018

Mark Zimmerman, MD, discusses controversies related to categorizing severity and identifying optimal treatment of depression.

Next post in Depressive Disorder

M Tewar, MD

All articles by M Tewar, MD

Fremanezumab Beneficial in Patients With Chronic Migraine and Moderate to Severe Depression

Assessment and Treatment of Depression: A Clinical Look at the Current Controversies

Psilocybin Gets Breakthrough Therapy Designation for Treatment-Resistant Depression